WPI Professor Dmitry Korkin and researchers in Senegal are using a unique type of artificial intelligence (AI) to develop a ...
In a small trial, Roivant's immune drug significantly outperformed placebo in clearing lesions caused by a rare skin disease.
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Researchers at Ben-Gurion University of the Negev (BGU) have discovered that a gene long known for shaping the skin's ...
A lack of understanding about what scabies is and how it’s treated could be behind the United Kingdom’s sudden spike in cases ...
By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, ...
Chronic itch has often been dismissed as a minor skin complaint; however, experts view it as a warning sign of deeper disease ...
Researchers have proposed a novel integrated framework to understand the complex progression of autoimmune skin diseases. A ...
Skin changes associated with peripheral artery disease (PAD) include discoloration, dryness, and shiny or smooth texture. If you’re living with PAD, you may also be at a higher risk of developing foot ...
According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.
By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, scientists at UNIGE are paving the way for a new diagnostic method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results